fda banning compounded semaglutide crackdown on off-brand Ozempic products set to take effect, threatening supply and access for many US FDA to hold off

Patients should seek immediate medical attention for severe, persistent abdominal pain while taking these medications, as this could indicate pancreatitis

The cost of wasted semaglutide is always less than the cost of injecting a compromised compound

Both prescribe compounded semaglutide and tirzepatide prepared by state-licensed compounding pharmacies

Retatrutide: The Triple Receptor Compound The compound at the center of this shift, retatrutide, hits three receptors at once: GLP-1, GIP, and glucagon

Tirzepatide is FDA approved and available now, while retatrutide is still in clinical trials

Key Takeaways: Triple-Action Mechanism : Retatrutide uniquely activates GLP-1, GIP, and glucagon receptors, profoundly enhancing weight loss, glycemic control, and metabolic flexibility